Health Care & Life Sciences » Medical Equipment & Supplies | Medite Cancer Diagnostics Inc.

Medite Cancer Diagnostics Inc.

Medite Cancer Diagnostics Inc.
Stock Exchange Other OTC
EPS
$0.15
Market Cap
$2.67 M
Shares Outstanding
86.2 M
Public Float
19.53 M

Profile

Address
4203 SW 34th Street
Orlando Florida 32811
United States
Employees -
Website http://www.medite-group.com
Updated 07/08/2019
MEDITE Cancer Diagnostics, Inc. is a medical technology company which engages in cancer diagnostics instruments and consumables for histology and cytology laboratories. It specializes in developing, manufacturing, and marketing of molecular biomarkers premium medical devices and consumables for detection, risk assessment and diagnosis of cancer, precancerous conditions, and related diseases. It operates through the following segments: United States, Germany, and Poland.

Financials

View All

Stephen Von Rump
CEO, CFO, Secretary, Treasurer & Director
Joel Stephen Kanter
Director